CRISPR-Cas9 is a revolutionary genome editing technology with a host of potential biotechnology applications and also, the subject of three-year long litigation between leading research institutes. During the period of 2011 to 2012, two research teams, one at the University of California-Berkeley and the other at the Harvard and Massachusetts Institute of Technology-affiliated Broad Institute, were researching the same mechanism simultaneously yet separately. Finally, by the end of 2012, Dr. Jennifer Doudna of UC Berkeley published her findings on how to transform CRISPR from a natural bacterial mechanism into a laboratory-based genome editing tool. In 2013, Feng Zhang of the…
Read More